Molecular basis for interaction between an essential protein complex and its regulator
The labs of Lauren Jackson, associate professor of biological sciences and biochemistry, and Todd Graham, Stevenson Professor of Biological Sciences at the College of Arts and Science and professor of cell and developmental biology, recently published a in the Journal of Cell Biology describing a significant interaction between an essential protein complex used for protein and lipid transport—the COPI complex—and its regulator protein.
The authors include Betty Xie and Cameron Cohen, two graduate students in the Jackson lab, and Swapneeta Date, senior scientist in the Graham lab. Together, the two groups established how COPI interacts with the regulator protein Glo3, a member of the ArfGAP protein family of enzymes. Disruptions of the interaction between COPI and Glo3 lead to deleterious effects in cells.
We sat down with Jackson to find out more about this research.

What issue/problem does your research address?
Our lab studies the cellular “FedEx system” that allows proteins and lipids to move between membrane-bound compartments. This work focused on COPI, which is required in all eukaryotes. Mutations in COPI are associated with multiple human diseases, including cancers and microcephalies, which are conditions in which a patient’s head is abnormally small. Pathogens, including viruses like SARS-CoV-2, also hijack COPI to take over cells.
While the field has previously established that molecules in the ArfGAP family affect COPI function, the mechanisms involved in this interaction have not been well understood. We sought to determine the basis for the interaction between COPI subunits and a specific ArfGAP protein, Glo3.
What was unique about your approach to the research?
We undertook a multi-disciplinary approach to address these questions using biochemistry, biophysics, computational artificial intelligence-based modeling, and in vivo approaches including fluorescence imaging in budding yeast. This combination of approaches allows us to use the molecular information generated from biochemical, biophysical, and computational studies to design hypotheses that could be used to test function directly in budding yeast, our model organism.
What were your findings?
We discovered a molecular “code” that explains how COPI recruits ArfGAP proteins. We identified specific amino acid residues on each protein that mediate the interaction between COPI and ArfGAP. We then tested how breaking the interaction affected the movement of transmembrane protein cargo using budding yeast as our model organism. Breaking this interaction specifically disrupted the shape of a key organelle called the Golgi, and it also misdirected specific cargo proteins to the wrong cellular location.

What do you hope will be achieved with the research results in the short and long terms?
Overall, many of these proteins are strongly conserved across species, which suggests our results will be relevant to human biology. This study provides a variety of molecular tools that we can use to dissect these important cellular events that drive essential membrane trafficking—the process of moving proteins and other molecules throughout the cell using membrane-bound vesicles.
What are the benefits of this research?
This research contributes to our understanding of fundamental biological processes in cellular sorting. Obtaining molecular information allows us to probe complex cellular sorting pathways so that we can understand human physiology and what goes wrong in disease states, such as in neurological disorders or cancers, when essential proteins are mutated or lost
Where is this research taking you next?
This work builds on our ongoing collaboration with Todd Graham’s lab. Together, the Jackson and Graham labs use a variety of methods to understand how the COPI/Glo3 interaction drives specific cellular sorting events (Jackson lab) and how the interaction is affected by post-translational modifications and sorting of SNAREs, a family of proteins that play essential roles in vesicle fusion events (Graham lab).
This article was written for Vanderbilt University’s School of Medicine Basic Sciences and was republished with permission.
Enjoy reading 91亚色传媒 Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from 91亚色传媒 Today
Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Exploring lipid metabolism: A journey through time and innovation
Recent lipid metabolism research has unveiled critical insights into lipid鈥損rotein interactions, offering potential therapeutic targets for metabolic and neurodegenerative diseases. Check out the latest in lipid science at the 91亚色传媒 annual meeting.

Melissa Moore to speak at 91亚色传媒 2025
Richard Silverman and Melissa Moore are the featured speakers at the 91亚色传媒 annual meeting to be held April 12-15 in Chicago.

A new kind of stem cell is revolutionizing regenerative medicine
Induced pluripotent stem cells are paving the way for personalized treatments to diabetes, vision loss and more. However, scientists still face hurdles such as strict regulations, scalability, cell longevity and immune rejection.

Engineering the future with synthetic biology
Learn about the 91亚色传媒 2025 symposium on synthetic biology, featuring applications to better human and environmental health.

Scientists find bacterial 鈥楢chilles鈥 heel鈥 to combat antibiotic resistance
Alejandro Vila, an 91亚色传媒 Breakthroughs speaker, discussed his work on metallo-尾-lactamase enzymes and their dependence on zinc.

Host vs. pathogen and the molecular arms race
Learn about the 91亚色传媒 2025 symposium on host鈥損athogen interactions, to be held Sunday, April 13 at 1:50 p.m.